Our News on Newswise

Newswise: PuzanovIgorOctober272017.jpg

Use of Pembrolizumab Provided Long-Term Benefits in Patients With Metastatic Melanoma, 10-Year Look Shows

A new 10-year analysis led by Igor Puzanov, MD, MSci, FACP, Director of Early Phase Clinical Trials and Chief of Melanoma at Roswell Park Comprehensive Cancer Center and published today in the journal JAMA Oncology provides new insights into an...
16-Jul-2020 4:05 PM EDT Add to Favorites

Newswise: iyer-renuka-landscape.jpg

Roswell Park Studies Highlight Emerging Treatment Options for Neuroendocrine Tumors

Two new studies led by Renuka Iyer, MD, Section Chief for Gastrointestinal Oncology at Roswell Park Comprehensive Cancer Center, highlight possible new treatment options for patients with neuroendocrine tumors (NETs) — a rare and hard-to-treat...
14-Jul-2020 11:00 AM EDT Add to Favorites

Newswise: AnuragSinghandJorgeGomez-Linac2June12201915.jpg

Number of Hospitalizations Can Be Important Clinical Indicator for Head, Neck Cancer Patients

Patients who were unexpectedly hospitalized for dehydration, fever or other ailments while undergoing radiation treatment for head and neck cancers were at a higher risk for less favorable outcomes, a new study from Roswell Park Comprehensive Cancer...
30-Jun-2020 4:00 PM EDT Add to Favorites

Newswise: gvhd-small-intestine-cells_hmohammadpourjpg.jpg

Roswell Park Suggests New Strategy for Controlling Graft vs. Host Disease in Blood/Marrow Transplant Recipients

New preclinical work by a team of researchers from Roswell Park Comprehensive Cancer Center’s Transplant and Cellular Therapy Program suggests that the risk of developing acute graft vs. host disease (GVHD) during allogeneic blood/marrow...
12-Jun-2020 12:30 PM EDT Add to Favorites

Newswise: adobestock_331558247.jpg

Cancer Researchers Have a Head Start in Fight Against COVID-19

Researchers at Roswell Park Comprehensive Cancer Center have been actively engaged in the effort to develop treatments or other control strategies that can help communities worldwide to address the impacts of the COVID-19 pandemic.
9-Jun-2020 5:30 PM EDT Add to Favorites

Newswise: StephenEdgeMD.jpg

Decisions to Stray From Clinical Oncology Pathways Are Often Justified, Roswell Park Analysis Shows

Clinical oncology pathways are an important tool, helping cancer care providers and their patients to zero in on the most appropriate care plan. But a treating professional’s decision to depart from the recommendations of these decision-support...
29-May-2020 1:25 PM EDT Add to Favorites

Newswise: thota_swapna.jpg

Targeted Drugs and Immunotherapies May Lower Risk of Therapy-Related Hematologic Cancers

While breakthrough treatments have emerged for several cancers over the last two decades, driving striking improvements in survival and other clinical outcomes, too little is known about the risk of therapy-related hematologic cancers following...
29-May-2020 11:05 AM EDT Add to Favorites

Newswise: Immunecellsubsetsinpancreatictumor1.jpg

Roswell Park Team Proposes Strategy for Making Pancreatic Tumors Respond to Checkpoint Inhibition

A possible new strategy for treating pancreatic cancer highlights the promise of collaboration between experts in both precision medicine and immunology. The findings from a team led by Agnieszka Witkiewicz, MD, and Erik Knudsen, PhD, at Roswell...
18-May-2020 10:15 AM EDT Add to Favorites

See All News

Our Experts on Newswise

Roswell Park: Racial Disparities From Cervical Cancer Are a Wake-Up Call

25-Jan-2017 10:05 AM EST

Dr. Igor Puzanov of @RoswellPark Cancer Institute Avail. To Comment on Chan/Zuckerberg $30b Pledge for #Medicalresearch

22-Sep-2016 3:05 PM EDT

Roswell Park's Dr. James Marshall Available to Interpret, Comment on Who Statement on Processed Meats and Cancer Risk

27-Oct-2015 5:05 PM EDT

Cancer-Specific Clinical Research Center: New Frontiers in Research at Roswell Park

Clinical trials are the frontier for targeted cancer drugs. Roswell Park Cancer Institute recently opened one of only a few clinical research centers in the U.S. focused exclusively on cancer. The Clinical Research Center, under the direction of...
4-Apr-2008 1:00 PM EDT

See All Experts

Our YouTube Videos

Youtube feed not yet configured. Is this your Newswise member page? Contact member@newswise.com to configure this module.


Roswell Park Comprehensive Cancer Center is a community united by the drive to eliminate cancer’s grip on humanity by unlocking its secrets through personalized approaches and unleashing the healing power of hope. Founded by Dr. Roswell Park in 1898, it is the only National Cancer Institute-designated comprehensive cancer center in Upstate New York. Learn more at www.roswellpark.org, or contact us at 1-800-ROSWELL (1-800-767-9355) or ASKRoswell@roswellpark.org.



Annie Deck-Miller
Sr. Media Relations Manager
Cancer research and treatment



Mary Cochrane
Associate Director


Heidi Findlay
Executive Director, Marketing and Communications


(716) 353-3716

Rebecca Vogt
Media Relations Specialist